1. Academic Validation
  2. Myeloid-derived suppressor cells-induced exhaustion of CD8 + T-cell participates in rejection after liver transplantation

Myeloid-derived suppressor cells-induced exhaustion of CD8 + T-cell participates in rejection after liver transplantation

  • Cell Death Dis. 2024 Jul 16;15(7):507. doi: 10.1038/s41419-024-06834-z.
Liu-Xin Zhou # 1 2 Yi-Zhou Jiang # 1 2 3 Xin-Qiang Li 4 Jin-Ming Zhang 1 2 Shi-Peng Li 5 Lin Wei 1 2 Hai-Ming Zhang 1 2 Guang-Peng Zhou 1 2 Xiao-Jie Chen 1 2 Li-Ying Sun 1 2 3 Zhi-Jun Zhu 6 7
Affiliations

Affiliations

  • 1 Liver Transplantation Center, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • 2 State Key Lab of Digestive Health, Beijing, China.
  • 3 Department of Critical Liver Diseases, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • 4 Organ Transplantation Center, Affiliated Hospital of Qingdao University, Qingdao, China.
  • 5 Department of Hepatopancreaticobiliary Surgery, Henan Provincial People's Hospital, Zhengzhou University, Zhengzhou, China.
  • 6 Liver Transplantation Center, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China. zhu-zhijun@outlook.com.
  • 7 State Key Lab of Digestive Health, Beijing, China. zhu-zhijun@outlook.com.
  • # Contributed equally.
Abstract

Liver transplantation (LT) rejection remains the most pervasive problem associated with this procedure, while the mechanism involved is still complicated and undefined. One promising solution may involve the use of myeloid-derived suppressor cells (MDSC). However, the immunological mechanisms underlying the effects of MDSC after LT remain unclear. This study is meant to clarify the role MDSCs play after liver transplantation. In this study, we collected liver tissue and peripheral blood mononuclear cells (PBMC) from LT patients showing varying degrees of rejection, as well as liver and spleen tissue samples from mice LT models. These samples were then analyzed using flow cytometry, immunohistochemistry and multiple immunofluorescence. M-MDSCs and CD8 + T-cells extracted from C57/BL6 mice were enriched and cocultured for in vitro experiments. Results, as obtained in both LT patients and LT mice model, revealed that the proportion and frequency of M-MDSC and PD-1 + T-cells increased significantly under conditions associated with a high degree of LT rejection. Within the LT rejection group, our immunofluorescence results showed that a close spatial contiguity was present between PD-1 + T-cells and M-MDSCs in these liver tissue samples and the proportion of CD84/PD-L1 double-positive M-MDSC was greater than that of G-MDSC. There was a positive correlation between the activity of CD84 and immunosuppressive function of M-MDSCs including PD-L1 expression and Reactive Oxygen Species (ROS) production, as demonstrated in our in vitro model. M-MDSCs treated with CD84 protein were able to induce co-cultured CD8 + T-cells to express high levels of exhaustion markers. We found that CD84 regulated M-MDSC function via expression of PD-L1 through activation of the Akt/STAT3 pathway. These results suggest that the capacity for CD84 to regulate M-MDSC induction of CD8 + T-cell exhaustion may play a key role in LT rejection. Such findings provide important, new insights into the mechanisms of tolerance induction in LT.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-15146
    98.64%, STAT3 抑制剂